{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:00:17Z","timestamp":1786125617319,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Intravenous (IV) alteplase with mechanical thrombectomy has been found to be superior to alteplase alone in select patients with intracranial large vessel occlusion. Current guidelines discourage the use of antiplatelet agents or heparin for 24 h following alteplase. However, their use is often necessary in certain circumstances during thrombectomy procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To study the safety and outcomes in patients who received blood thinning medications for thrombectomy after IV Tissue-Type plasminogen activator (tPA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This is a multicenter retrospective review of the use of antiplatelet agents and\/or heparin in patients within 24 h following tPA administration. Patient demographics, comorbidities, bleeding complications, and discharge outcomes were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A series of 88 patients at 9 centers received antiplatelet medications and\/or heparin anticoagulation following IV alteplase for revascularization procedures requiring stenting. The mean National Institutes of Health Stroke Scale (NIHSS) on admission was 14.6. Reasons for use of a stent included internal carotid artery occlusion in 74% of patients. Thrombolysis in cerebral infarction (TICI) 2b-3 revascularization was accomplished in 90% of patients. The rate of symptomatic intracranial hemorrhage (sICH) was 8%; this was not significantly different than the sICH rate for a matched group of patients not receiving antiplatelets or heparin during the same time frame. Functional independence at 90 d (modified Rankin Scale 0-2) was seen in 57.8% of patients. All-cause mortality was 12%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The use of antiplatelet agents and heparin for stroke interventions following IV alteplase appears to be safe without significant increased risk of hemorrhagic complications in this group of patients when compared to control data and randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyaa530","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T15:12:58Z","timestamp":1605280378000},"page":"746-750","source":"Crossref","is-referenced-by-count":5,"title":["The Use of Antiplatelet Agents and Heparin in the 24-Hour Postintravenous Alteplase Window for Neurointervention"],"prefix":"10.1227","volume":"88","author":[{"given":"Mandy J","family":"Binning","sequence":"first","affiliation":[{"name":"Global Neurosciences Institute, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Global Neurosciences Institute, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McAree","sequence":"additional","affiliation":[{"name":"Global Neurosciences Institute, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Veznedaroglu","sequence":"additional","affiliation":[{"name":"Global Neurosciences Institute, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Felbaum","sequence":"additional","affiliation":[{"name":"Medstar Georgetown University Hospital, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Arthur","sequence":"additional","affiliation":[{"name":"University of Tennessee, Memphis-Semmes-Murphey Clinic, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Goyal","sequence":"additional","affiliation":[{"name":"University of Tennessee, Memphis-Semmes-Murphey Clinic, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey Q","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Health, Lexington, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tschoe","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Health, Lexington, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Webster","family":"Crowley","sequence":"additional","affiliation":[{"name":"Rush University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Levy","sequence":"additional","affiliation":[{"name":"University at Buffalo Neurosurgery, Williamsville, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Vakharia","sequence":"additional","affiliation":[{"name":"University at Buffalo Neurosurgery, Williamsville, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2784-5957","authenticated-orcid":false,"given":"Hamid H","family":"Rai","sequence":"additional","affiliation":[{"name":"University at Buffalo Neurosurgery, Williamsville, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-4273","authenticated-orcid":false,"given":"Aditya S","family":"Pandey","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badih J","family":"Daou","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih G","family":"Tawk","sequence":"additional","affiliation":[{"name":"Mayo Clinic-Jacksonville, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Ringer","sequence":"additional","affiliation":[{"name":"Mayfield Brain & Spine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M","family":"Liebman","sequence":"additional","affiliation":[{"name":"Global Neurosciences Institute, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Endovascular Neurosurgery Research Group (ENRG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4]]},"reference":[{"issue":"12","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"7","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke","volume":"380","author":"Ma","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a Meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"Jama"},{"issue":"11","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke","volume":"372","author":"Jovin","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-Retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S1474-4422(16)30177-6","article-title":"Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial","volume":"15","author":"Bracard","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1474-4422(18)30242-4","article-title":"Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data","volume":"17","author":"Roman","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0000000000003083","article-title":"Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment","volume":"87","author":"Jeong","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/STROKEAHA.118.022128","article-title":"Intravenous tPA (Tissue-Type plasminogen activator) in patients with acute ischemic stroke taking Non-Vitamin K antagonist oral anticoagulants preceding stroke","volume":"49","author":"Jin","year":"2018","journal-title":"Stroke"},{"issue":"8","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/STROKEAHA.118.024733","article-title":"Emergent carotid stenting plus thrombectomy after thrombolysis in tandem strokes","volume":"50","author":"Anadani","year":"2019","journal-title":"Stroke"},{"issue":"13","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jcin.2018.05.036","article-title":"Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions","volume":"11","author":"Papanagiotou","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/STROKEAHA.118.021893","article-title":"Emergent management of tandem lesions in acute ischemic stroke","volume":"50","author":"Jadhav","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/88\/4\/746\/36592694\/nyaa530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:58:58Z","timestamp":1786121938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyaa530","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}